B&L and Alcon settle dispute amicably

Article

Bausch & Lomb and Alcon have settled a lawsuit that was filed recently regarding Alcon's promotional claims about Bausch & Lomb's ReNu MultiPlus solution.

Bausch & Lomb and Alcon have settled a lawsuit that was filed recently regarding Alcon's promotional claims about Bausch & Lomb's ReNu MultiPlus solution.

Bausch & Lomb claimed that Alcon's promotional use of a chart to demonstrate the safety of contact lens solutions could negatively influence patients and/or doctors. The chart shows the safety of different solutions based on corneal staining tests, rating them with a colour coding system: green is safe, yellow means use with caution and red indicates the solution is unsafe. Bausch & Lomb alleged that the chart was produced without scientific studies or clinical evidence to back it up.

Alcon has agreed to change the red/yellow colour scheme and in light of this the lawsuit has been dismissed.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.